Thesis on cases of Cutis Laxa

Dr Thatjana Gardeitchik was a successful candidate with her thesis defence on 9th September 2024.

The title is: « Curious cases of Cutis Laxa , Insights into the diagnostics and patho-mechanisms of metabolic cutis laxa syndromes”.

You can find it online, in English only

(https://www.globalacademicpress.com/ebooks/thatjana_gardeitchik/)

In the Media

02nd September 2024 

Info-Chalon (newspaper) Official opening of the resource center for tele-expertise in dermatology in Chalon-sur-Saône.

Read the article (in French)

 

10th September 2024

 Le Journal de Saone et Loire (Newspaper) Official opening of the resource center for tele-expertise in dermatology in Chalon-sur-Saône.

Read the article (in French)

 

29th November 2024

Charente Libre  Handing over the € 2,500 check to the benefit of Cutis Laxa Internationale by  Triathlon de Sireuil

Read the article (in French)

 

Autumn 2024

la Gazette Bonsoise Cutis Laxa Internationale, beyond the frontiers of Bons en Chablais

Read the article (in French)

In our hearts and thoughts

Alas, we are very sad to let you know about two deaths:

Lucille, who joined our private Facebook group in 2010 and was an active member

and

Safaa who was only 18.

To their mourning families we give our support and thoughts in this difficult time.

Since we set up CLI in 2002, 27 patients have passed away. They remain in our hearts and thoughts.

 

Online Activities

According to the rythm established in 2024, attending numerous meetings and webinars online meant better progress with some projects and greater knowledge and competencies to carry on raising patients’ voice

Dermatology Days of Paris

03rd-06th December 2024

Dermatology Days of Paris (JDP)

Thanks to our stand during the JDP, I have had the great joy, more than 30 years later, to see again Dr Karim CHERTI.

At that time, he was a junior doctor in the genodermatosis unit at Hôpital Saint Louis in Paris. He was a member of the team who diagnosed my daughter, Cécile, and wrote his thesis on her case.

It was a very moving moment for both of us.

6th Conference of the French Federation for Skin (FFP)

03rd December 2024

6th Conference of the French Federation for Skin (FFP)

This event is unmissable: the opportunity to gather together, evoke the achievements of the year and explore future projects in round-tables and interactive workshops.

It was also the last time I was leading the FFP Conference as my 3 years mandate chairing the FFP has come to its end.

La Sorbonne University of the Patients

Marie-Claude Boiteux was interviewed for the videos used during the Masterclass at the University for Patients in La Sorbonne (in French) (https://universitedespatients-sorbonne.fr/). The title of the presentation is “From loneliness to an International Organisation”.   see it  here (in French)

Patient Forum

26th November 2024

Pfizer Patient Forum

Marie-Claude Boiteux participated in a roundtable on  « Minimising obstacles and maximizing impact: key learnings from pilot projects and advice for action”.

THANK YOU

A huge THANK YOU to the leading team of the sport events organised in Sireuil, France (Trail du Brin d’Aillet and Triathlon). Thanks for faithfully supporting us, thanks to the energy you put in organising those events, thanks to the volunteers who work with you and support those sport events.Thanks also, of course, to all the sportsmen/women who participate: you are handing over € 2,500. That is enormous for us !!!

Thanks to you, we will be able to help patients come to Ghent, Belgium, to attend the Cutis Laxa Days and benefit from a consultation with Pr Bert Callewaert, worldwide expert for Cutis Laxa.

On behalf of of all the patients, I am deeply grateful to you.

Marie-Claude Boiteux, Chair

FIMARAD Annual Meeting

08th November 2024

FIMARAD Annual Meeting

Patient organisation representatives attended the Annual Meeting of the French Network for Rare Skin Disorders.

On this occasion, they especially mentioned the progress of the working group  « Diagnosis roving and impasse » with the analysis of the patient survey. The results of this survey are planned for publication